Modified GRF 1-29 is also known as Mod GRF 1-29, but even more commonly known as CJC-1295 without DAC. It is a protein that is 29 amino acids long and it is a GHRH analogue. CJC-1295 without DAC acts on receptors at the pituitary gland to stimulate the release of Human Growth Hormone.
CJC-1295 without DAC could be referred to more properly as a second generation derivative of GHRH. GHRH is modified to create what is known as Releasing Factor (GRF) 1-29, also known as Sermorelin. GRF 1-29 is then further modified to create Mod GRF 1-29 which is CJC-1295 without DAC.
CJC-1295 can be used for any purpose of performance enhancement, although fat loss or recomping may be where it stands out the most. For the off-season athlete looking to pack on more size, CJC-1295 is not a very good choice, at least not when used alone.
Although it will promote anabolic activity, the overall anabolism it promotes will not be all that significant. However, when combined with other performance enhancing drugs, the individual may find he gets more out of them due to the increase in HGH and IGF-1 levels. He should also find that due to a stronger metabolism he is able to stay leaner when bulking than he may have otherwise.
This is not a license to eat like a pig; you can still gain fat when using CJC-1295 but you should have an easier time controlling fat gain when the peptide is in play. You may be able to get away with more than you would otherwise, but how much will be genetically dependent.
It increases protein synthesis and stimulates the growth of new muscle tissue
1.Allows for normal growth in short children with GH deficiency.
2.Increases muscle mass (and physical strength if combined with moderate exercise).
3.Reduces wrinkling of the skin and some other effects of skin aging.
4.Re-grows internal organs that have atrophied with age.
5.Causes hyperplasia, the increase of more muscle cells.
6.It increases muscle mass through the creation of new muscle cells (which differs from hypertrophy).
7.It promotes lipolysis, which results in the reduction of adipose tissue (body fat).
8.Increased bone density.
9.Faster recovery from exercise, exertion, and injuries.
10.Strengthen the immune system.
Research study participants for often cycle doses 2-3 times per day (ex: before breakfast, before bed, and after exertion) for a period up to several weeks. These cycles, or pulses are meant to closely mimic natural secretion of GH. For CJC 1295, dosing is less frequent since the half-life with DAC is up to 8 days. Therefore, the cycle for CJC 1295 with DAC calls for once weekly injections that result in an overall increase of secretion of GH. At this point, research does not show any significant advantage for one cycle over the other, so it is a matter of personal preference.
CJC-1925 is a sterile, non-pyrogenic, white lyophilized powder intended for subcutaneous or intramuscular injection, after reconstitution with sterile Water for Injection. CJC-1295 can be injected subcutaneously with an insulin syringe. Dose per injection: 2mg. Injections per vial: 1 X 2mg dosages Amount to Inject: If you have used 0.5ml of water for mixing then a 2mg dosage = 0.50ml (or 50 units on Insulin Syringe). If you have used 1ml of water then a 2mg dosage = 1ml (or 100 units). Sample Injection Frequency: 2mg injected once per week (due to its long half-life).
If you are interested in CJC-1295,please contact me:
|CJC1295 without DAC||CAS 863288-34-0||2mg/vial|
|CJC1296 with DAC||CAS 863288-34-0||2mg/vial|
|Pentadecapeptide BPC 157||2mg/vial|
|AOD 9604||CAS 221231-10-3||2mg/vial|
|Triptorelin Acetate||CAS 57773-63-4||2mg/vial|
|HGH Fragment 176-191||2mg/vial|